FindTrial
Sign In

Study to evaluate the accuracy of anuPath nano Glucometer

A comparative clinical evaluation of the anuPath nano blood glucose monitoring system against Accu- check instant and central laboratory venous samples. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/111809
Enrollment
500
Registered
2026-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E08-E13- Diabetes mellitus

Interventions

Intervention1: Nil: Nil

Sponsors

PathShodh Healthcare Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consenting adults greater than or equal to 18 years with or without a prior diagnosis of diabetes mellitus.

Exclusion criteria

Exclusion criteria: Patients who are critically ill severely dehydrated or unable to provide informed consent.

Design outcomes

Primary

MeasureTime frame
To evaluate the clinical accuracy of the anuPath nano glucometer in measuring blood glucose compared to the reference laboratory analyzer, adhering to ISO 15197 accuracy criteria.Timepoint: baseline—

Secondary

MeasureTime frame
To compare the operational consistency & variance between the anuPath nano & the Accu-Chek Instant glucometer in a clinical setting.Timepoint: baseline—

Countries

India

Contacts

Public ContactDr Bhavana Sosale

Diacon Hospital Pvt Ltd

bhavanasosale@gmail.com9449478512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026